|
|
|
|
|
|
|
|
|
|
 
|
Pancreas Cancer
News and Archives |
|
A Phase II Study of High-Dose
24 Hour Continuous Infusion 5-FU and Leucovorin and Low-Dose
PALA for Patients with Advanced Pancreatic Adenocarcinoma: A
Southwest Oncology Group Study Invest New Drugs. 2004 Aug;22(3):335-41. PMID: 15122082
|
|
 |
|
|
For educational
purposes only; not to be relied upon Please read Pancreatica Disclaimer |
|
 Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us |
|
|
|
|
|
www.pancreatica.org |